Loading stock data…
TuHURA Biosciences, Inc. (HURA)
$2.29+0.13 (+6.02%)
After Hours$2.34+0.05 (+2.18%)· Last close Jun 29
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
TuHURA Biosciences, Inc. in the Healthcare sector is trading at $2.29 with a market capitalization of $135M. Wall Street consensus targets $8.04 (5 analysts), implying a +251.1% move over the next 12 months. The stock is currently 41% below its 52-week high of $3.90, remaining 22.5% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +251.1% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$7.53M↓ | -$4.38M↑ | -$6.59M↑ | -$9.55M↓ | -$6.35M |
| Net Income | -$7.54M↓ | -$6.76M↑ | -$7.10M↑ | -$9.52M↓ | -$6.66M |
Peer Comparison
JNJUNHPFE
Fundamentals
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome prim...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$135.01M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-133.35%
Volume
Today's trading volume
779,711
Recent News
Is TuHURA Biosciences (HURA) One of the Unstoppable Stocks That Could Double Your Money?
TuHURA Biosciences Inc. (NASDAQ:HURA) is one of the 10 Unstoppable Stocks That Could Double Your Money. TuHURA Biosciences Inc. (NASDAQ:HURA) is one of the unstoppable stocks that could double your money. TuHURA announced its financial results for Q4 and the full year. The company is advancing its Phase 3 trial for IFx-2.0 as an adjunctive […]
TuHURA Biosciences, Inc.'s (NASDAQ:HURA) Shift From Loss To Profit
TuHURA Biosciences, Inc. ( NASDAQ:HURA ) is possibly approaching a major achievement in its business, so we would like...
TuHURA Biosciences, Inc.'s (NASDAQ:HURA) last week's 11% decline must have disappointed retail investors who have a significant stake
NasdaqCM:HURA 1 Year Share Price vs Fair Value Explore TuHURA Biosciences's Fair Values from the Community and select...